SCHEMBL28396204

SCHEMBL28396204

COc1cc([N+](=O)[O-])c(C#N)cc1OCCCC1CNCCO1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2C P18825 1/20 0.42
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.40
HPGD P15428 1/20 0.40
CYP2C19 P33261 1/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CHEK1 O14757 3/20 0.37
SLC6A2 P23975 3/20 0.36
SLC6A4 P31645 3/20 0.36
EPHA2 P29317 7/20 0.36
ADRB2 P07550 1/20 0.35
HTR1A P08908 1/20 0.35
HTR2A P28223 1/20 0.35
ADRA1A P35348 1/20 0.35
HTR2B P41595 1/20 0.35
SLC6A3 Q01959 1/20 0.35
KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28392888 0.84 ADRA2C (0.46) ADRA2CCHEK1SLC6A2SLC6A4EPHA2
SCHEMBL28395688 0.82 ADRA2C (0.41) ADRA2CMEN1HTTKMT2AREN
SCHEMBL28396220 0.82 PKM (0.42) ADRA2CMEN1ALDH1A1CYP1A2HPGD
SCHEMBL28341717 0.82 PKM (0.42) ADRA2CMEN1ALDH1A1CYP1A2HPGD
Morpholine SCHEMBL25272802 0.79 MAPT (0.41) MEN1ALDH1A1CYP1A2HPGDCYP2C19
SCHEMBL25271253 0.79 ALDH1A1 (0.35) MEN1ALDH1A1CYP1A2HPGDCYP2C19
SCHEMBL17922740 0.76 ALDH1A1 (0.42) MEN1ALDH1A1CYP1A2HPGDCYP2C19
SCHEMBL2163708 0.76 ALDH1A1 (0.42) MEN1ALDH1A1CYP1A2HPGDCYP2C19
SCHEMBL29375590 0.76 MAPT (0.41) MEN1ALDH1A1CYP1A2HPGDCYP2C19
SCHEMBL2164504 0.76 MAPT (0.41) MEN1ALDH1A1CYP1A2HPGDCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110747489-B Electroreduction preparation method of intermediate of anticancer drug gefitinib and analogue thereof 湖南大学 2021-05-07 CN disclosed
CN-110747489-A Electroreduction preparation method of intermediate of anticancer drug gefitinib and analogue thereof 湖南大学 2020-02-04 CN disclosed